Close Menu
Journal of Pharmacology and Pharmacotherapeutics
    Browse
    • Home
    • Browse Issues
      • In Press
      • Current Issue
      • Past Issues
    • About
      • About Journal
      • Editorial Board
      • Bibliographic Listings
    • For Authors
      • Submission Guidelines
      • Submit Article
    • Contact
    Facebook X (Twitter) Instagram
    Journal of Pharmacology and PharmacotherapeuticsJournal of Pharmacology and Pharmacotherapeutics
    • Journal Homepage (SAGE)
    • Submission Guidelines
    Facebook X (Twitter) Instagram
    Submit
    • Home
    • Browse Issues
      • In Press
      • Current Issue
      • Past Issues
    • About
      • About Journal
      • Editorial Board
      • Bibliographic Listings
    • For Authors
      • Submission Guidelines
      • Submit Article
    • Contact
    Journal of Pharmacology and Pharmacotherapeutics
    Home»Uncategorized»Downregulation of Bcl-2 Family Expression and Enhanced DNA Fragmentation in HCT116 by Thymoquinone
    Uncategorized

    Downregulation of Bcl-2 Family Expression and Enhanced DNA Fragmentation in HCT116 by Thymoquinone

    July 22, 20261 Min Read
    Share
    Facebook Twitter Email

    Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print.
    BackgroundNigella sativais the source of thymoquinone (TQ), an active phenolic compound with numerous pharmacological properties, including anti-tumor, anti-angiogenic, and antioxidant activities. Nevertheless, the mechanism by which TQ exerts its …

    Read Original Source

    Previous ArticleSimvastatin Mediated Suppression of Epithelial-Mesenchymal Transition: A Potential Therapeutic Strategy for Breast Cancer
    Next Article Integrating Drug Utilisation Review and Medication Regimen Complexity Index to Enhance Safety and Adherence in Gynaecological Pharmacotherapy

    Related Articles

    Vestibular Stimulation as a Modulator of Metabolic Function: Implications for Diabetes Mellitus Management

    Uncategorized

    Integrating Drug Utilisation Review and Medication Regimen Complexity Index to Enhance Safety and Adherence in Gynaecological Pharmacotherapy

    Uncategorized

    Hesperetin and Isoliquiritigenin Ameliorates the Hepatic and Renal Complications in Type 2 Diabetic Rats

    Uncategorized
    Read Now
    Uncategorized

    Vestibular Stimulation as a Modulator of Metabolic Function: Implications for Diabetes Mellitus Management

    July 25, 2026

    Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. Metabolic disorders, including diabetes mellitus and obesity,…

    AgomiR-based Therapeutic Targeting of Oncogenic Pathways Regulated by miR-466 in Adrenocortical Carcinoma

    July 23, 2026

    l-Arginine Attenuates Brain Dysfunction in Heat-stress Rat Model via Modulating Nitric Oxide-dependent Pathway

    July 23, 2026
    Editor picks

    WITHDRAWN – Administrative Duplicate Publication: ML-powered Internet of Medical Things Structure for Heart Disease Prediction

    February 18, 2025

    Exploring Interleukin-6 Inhibitor Antibodies in Combatting SARS-CoV-2 and Its Mutated Variants: Challenges and Future Directions

    February 18, 2025

    Low Back Pain Management Through Bowel Lavage (Panchaprasrutik Basti)—A Single Arm Clinical Trial

    February 18, 2025
    About Journal
    About Journal

    The Journal of Pharmacology and Pharmacotherapeutics (JPP) is an open access, peer-reviewed journal that publishes high-quality articles pertaining to basic research and clinical studies in the domains of Pharmacology and Pharmacotherapeutics.

    We're accepting new partnerships right now.

    Email Us: editor.jpp@phcog.net

    Facebook X (Twitter) RSS
    Our Picks

    WITHDRAWN – Administrative Duplicate Publication: ML-powered Internet of Medical Things Structure for Heart Disease Prediction

    February 18, 2025

    Exploring Interleukin-6 Inhibitor Antibodies in Combatting SARS-CoV-2 and Its Mutated Variants: Challenges and Future Directions

    February 18, 2025

    Low Back Pain Management Through Bowel Lavage (Panchaprasrutik Basti)—A Single Arm Clinical Trial

    February 18, 2025
    Stay Connected

    Contact Editor-In-Chief
    Editor, Journal of Pharmacology and Pharmacotherapeutics
    Manuscript TechnoMedia LLP,
    #9, Vinnse Tower, Wheeler Road Extn.
    St. Thomas Town, 560084, Bangalore, INDIA
    Email: editor.jpp@phcog.net


    • Home
    • Site Map
    © 2026 JPharmacol.com Designed & Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.